Abstract
An estimated 9 to 22 % of the pediatric age group are affected by the extremely broad range of childhood neurological disorders, which includes autism and other pervasive developmental disorders (PDD). As with most all of the neurodevelopmental disorders, the PDD spectrum disorders demonstrate a tremendous degree of clinical, biochemical, and genetic heterogeneity. In the great majority of cases, the underlying molecular defects are not known and both diagnosis and appropriate treatment remain challenging. Gene expression profiling using DNA microarrays is a useful tool to characterize cellular samples from patients with childhood neurological disorders. There are two principal goals in the characterization of transcriptional changes in these disorders: 1) Accurate molecular diagnosis of disorders in the absence of clear clinical or biochemical diagnostic markers. Additionally, analysis of transcriptional patterns can be used to generate sub-classifications of individual disorders. 2) Identificat ion of cellular systems that are disrupted in the disorder. Changes in the expression of individual genes as well as functionally related groups of genes can delineate biochemical pathways that are perturbed in a disorder. Both of these goals are ultimately directed at the development of effective therapeutic strategies. This review describes recent advances in these areas, discussing issues relevant to the study of gene expression in pediatric neurodevelopmental disorders.
Keywords: Microarrays, Brain Disorders, pervasive devleopment disorder pdd, hyperactivity disorder adhd, obseeive-compulsive disorder ocd
Current Genomics
Title: The Use of Microarrays to Study Childhood Developmental Brain Disorders
Volume: 3 Issue: 1
Author(s): C. Colantuoni, A. Comi, A. E. Purcell and J. Pevsner
Affiliation:
Keywords: Microarrays, Brain Disorders, pervasive devleopment disorder pdd, hyperactivity disorder adhd, obseeive-compulsive disorder ocd
Abstract: An estimated 9 to 22 % of the pediatric age group are affected by the extremely broad range of childhood neurological disorders, which includes autism and other pervasive developmental disorders (PDD). As with most all of the neurodevelopmental disorders, the PDD spectrum disorders demonstrate a tremendous degree of clinical, biochemical, and genetic heterogeneity. In the great majority of cases, the underlying molecular defects are not known and both diagnosis and appropriate treatment remain challenging. Gene expression profiling using DNA microarrays is a useful tool to characterize cellular samples from patients with childhood neurological disorders. There are two principal goals in the characterization of transcriptional changes in these disorders: 1) Accurate molecular diagnosis of disorders in the absence of clear clinical or biochemical diagnostic markers. Additionally, analysis of transcriptional patterns can be used to generate sub-classifications of individual disorders. 2) Identificat ion of cellular systems that are disrupted in the disorder. Changes in the expression of individual genes as well as functionally related groups of genes can delineate biochemical pathways that are perturbed in a disorder. Both of these goals are ultimately directed at the development of effective therapeutic strategies. This review describes recent advances in these areas, discussing issues relevant to the study of gene expression in pediatric neurodevelopmental disorders.
Export Options
About this article
Cite this article as:
Colantuoni C., Comi A., Purcell E. A. and Pevsner J., The Use of Microarrays to Study Childhood Developmental Brain Disorders, Current Genomics 2002; 3 (1) . https://dx.doi.org/10.2174/1389202023350660
DOI https://dx.doi.org/10.2174/1389202023350660 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
Call for Papers in Thematic Issues
Advanced AI Techniques in Big Genomic Data Analysis
The thematic issue on "Advanced AI Techniques in Big Genomic Data Analysis" aims to explore the cutting-edge methodologies and applications of artificial intelligence (AI) in the realm of genomic research, where vast amounts of data pose both challenges and opportunities. This issue will cover a broad spectrum of AI-driven strategies, ...read more
Advanced Computational Algorithms and Artificial Intelligence in Clinical Pharmacogenomics
In the era of personalized medicine, understanding the relationship between genetics and drug response is crucial. This issue delves into innovative methodologies, leveraging deep computational analysis and artificial intelligence, to enhance the field of Clinical Pharmacogenomics. The interdisciplinary approach harnesses the power of advanced high-throughput genotyping technologies, sophisticated computational analysis, ...read more
Applications of Single-cell Sequencing Technology in Reproductive Medicine
Single cell sequencing (SCS) technology utilizes individual cells' genetic material to sequence their genome, transcriptome, and epigenetics at the molecular level. It offers insights into cell heterogeneity and enables the study of limited biological materials. Since its recognition as a valuable technique in 2011, single cell sequencing has yielded numerous ...read more
Big Data in Cancer Research
Cancer is a significant threat to human life and health, remaining a highly aggressive killer. It is a leading cause of death worldwide and represents a crucial medical issue for humanity. However, in the past decade, the effectiveness of new synthetic anticancer agents has not matched the current clinical speculation. ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Histone Methyltransferase Inhibitors: Novel Epigenetic Agents for Cancer Treatment
Current Medicinal Chemistry Recent Developments on 1,2,4-Triazole Nucleus in Anticancer Compounds: A Review
Anti-Cancer Agents in Medicinal Chemistry Perioperative Management of Female Hormone Medications
Current Clinical Pharmacology Milk Thistle: A Future Potential Anti-Osteoporotic and Fracture Healing Agent
Current Drug Targets Further Vitamin D Analogs
Current Vascular Pharmacology Isothiocyanates as Cancer Chemopreventive Agents: Their Biological Activities and Metabolism in Rodents and Humans
Current Drug Metabolism Abatacept and Glomerular Diseases: The Open Road for the Second Signal as a New Target is Settled Down
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Factors Promoting Tamoxifen Resistance in Breast Cancer via Stimulating Breast Cancer Stem Cell Expansion
Current Medicinal Chemistry Selective Estrogen Receptor Modulators (SERMs): Effects on Multiple Organ Systems
Current Medicinal Chemistry Phytochemicals and Antioxidants: An Evaluation in Understanding the Human Lifeline
Current Nutrition & Food Science Potential Use of Polymeric Nanoparticles for Drug Delivery Across the Blood-Brain Barrier
Current Medicinal Chemistry Establishing Maternal Tolerance: The Role of Regulatory T Cells (Tregs) in Pregnancy and Pathophysiology of Preeclampsia
Current Women`s Health Reviews Serpins for Diagnosis and Therapy in Cancer
Cardiovascular & Hematological Disorders-Drug Targets Safety of Systemic Biologic Agents in the Treatment of Non-malignant Skin Disorders
Current Drug Safety Aging and Systemic Lupus Erythematosus - Immunosenescence and Beyond
Current Aging Science Glycerophospholipid Synthesis as a Novel Drug Target Against Cancer
Current Molecular Pharmacology Cathepsin D as a Promising Target for the Discovery of Novel Anticancer Agents
Current Cancer Drug Targets CDC25A and B Dual-Specificity Phosphatase Inhibitors: Potential Agents for Cancer Therapy
Current Medicinal Chemistry Salinomycin Modulates the Expression of mRNAs and miRNAs Related to Stemness in Endometrial Cancer
Current Pharmaceutical Biotechnology Regulatory Approaches to Nonclinical Reproductive Toxicity Testing of Anti-Cancer Drugs
Anti-Cancer Agents in Medicinal Chemistry